Active ingredients: Abacavir
Ziagen 300 mg film-coated tablets.
Film-coated tablet (tablets).
The scored tablets are yellow, biconvex, capsule shaped and are engraved with ‘GX 623’ on both sides.
The tablet can be divided into equal halves.
Each film-coated tablet contains 300 mg of abacavir (as sulfate).
For the full list of excipients see section 6.1.
Abacavir is a potent selective inhibitor of HIV-1 and HIV-2. The mechanism of action as to HIV, is the inhibition of the enzyme reverse transcriptase of HIV, an event that causes chain termination and stopping the replication cycle of the virus.
Tablet Core:
Microcrystalline cellulose
Sodium starch glycollate
Magnesium stearate
Colloidal anhydrous silica
Tablet Coating:
Triacetin
Methylhydroxypropylcellulose
Titanium dioxide
Polysorbate 80
Iron oxide yellow
Child-resistant foil blister packs (polyvinyl chloride/aluminium/paper) containing 60 tablets.
ViiV Healthcare UK Limited, 980 Great West Road, Brentford, Middlesex, TW8 9GS, United Kingdom
EU/1/99/112/001
Date of first authorisation: 8 July 1999
Date of latest renewal: 21 March 2014